Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855162 · ClinicalTrials.gov registry record
Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 74
- Enrollment target
NCT04855162 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 74 participants.
The verdict
NCT04855162 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2021-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04855162
The ClinicalTrials.gov registry entry for NCT04855162 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04855162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04855162 about?
NCT04855162 is a clinical study titled "Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning". The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
What is the current status of trial NCT04855162?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2021-07-21. Estimated completion is 2021-10-23.
Who is sponsoring clinical trial NCT04855162?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.